Cholesterol emboli syndrome occurring after administration of tissue plasminogen activator.

Baldwin, Sharolyn Hoover

Cholesterol emboli syndrome occurring after administration of tissue plasminogen activator. [electronic resource] - Journal of the Mississippi State Medical Association Apr 2002 - 108 p. digital

Publication Type: Case Reports; Journal Article

0026-6396


Embolism, Cholesterol--chemically induced
Fibrinolytic Agents--adverse effects
Humans
Male
Middle Aged
Tissue Plasminogen Activator--adverse effects